- Home
- RNST vs PTGX Comparison
RNST vs PTGX Comparison
Compare RNST & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNST
- PTGX
- Stock Information
- Founded
- RNST 1904
- PTGX 2006
- Country
- RNST United States
- PTGX United States
- Employees
- RNST N/A
- PTGX N/A
- Industry
- RNST Major Banks
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- RNST Finance
- PTGX Health Care
- Exchange
- RNST Nasdaq
- PTGX Nasdaq
- Market Cap
- RNST 3.7B
- PTGX 3.7B
- IPO Year
- RNST N/A
- PTGX 2016
- Fundamental
- Price
- RNST $38.73
- PTGX $58.86
- Analyst Decision
- RNST Buy
- PTGX Strong Buy
- Analyst Count
- RNST 6
- PTGX 9
- Target Price
- RNST $42.20
- PTGX $70.44
- AVG Volume (30 Days)
- RNST 517.4K
- PTGX 880.7K
- Earning Date
- RNST 10-21-2025
- PTGX 11-06-2025
- Dividend Yield
- RNST 2.25%
- PTGX N/A
- EPS Growth
- RNST N/A
- PTGX N/A
- EPS
- RNST 2.24
- PTGX 0.80
- Revenue
- RNST $735,575,000.00
- PTGX $209,180,000.00
- Revenue This Year
- RNST $42.66
- PTGX N/A
- Revenue Next Year
- RNST $12.00
- PTGX $185.11
- P/E Ratio
- RNST $17.45
- PTGX $73.51
- Revenue Growth
- RNST 17.23
- PTGX N/A
- 52 Week Low
- RNST $26.97
- PTGX $33.31
- 52 Week High
- RNST $40.40
- PTGX $61.89
- Technical
- Relative Strength Index (RSI)
- RNST 53.35
- PTGX 54.53
- Support Level
- RNST $37.29
- PTGX $54.50
- Resistance Level
- RNST $40.40
- PTGX $61.04
- Average True Range (ATR)
- RNST 0.78
- PTGX 2.72
- MACD
- RNST -0.11
- PTGX -0.07
- Stochastic Oscillator
- RNST 46.30
- PTGX 59.00
About RNST Renasant Corporation
Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: Community banks, Insurance, and Wealth management. With its Community banks segment, the company provides a range of financial services to individuals and small businesses. Its Insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.